Hypovitaminosis D Clinical Trial
Official title:
Importance of Dosing Regimen for the Effect of Vitamin D Supplementation
Verified date | September 2017 |
Source | University of Tromso |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Vitamin D is a hormone with effects not only on the skeleton, but on most tissues in the body. Lack of vitamin D is associated with cardio-vascular disease (CVD), type 2 diabetes, cancer, infectious and immunological diseases, as well as risk factors for these diseases. However, intervention studies with vitamin D have been inconclusive regarding diseases and risk factors. This could be due to inclusion of subjects already vitamin D sufficient, and short and underpowered studies. In addition, there are indications that the dosing regimens may be important, so that daily doses with vitamin D are more efficient than intermittent doses, which so far have been generally used. This could be related to the concentration of circulating and thereby intracellular vitamin D concentrations, which probably is dependent on daily vitamin D doses. This will be tested in the present study where 60 subjects will be randomized to vitamin D 160 000 once, vitamin D 4000 IU/day, or placebo for four weeks. The primary endpoints will be effects on serum hepcidin and plasma cathelicidin after 4 weeks, with effects on serum PTH, RNA expression and microRNA in peripheral blood, telomerase activity in peripheral blood mononuclear cells and the ration between serum 1,25(OH)2D and 24,25(OH)2D as secondary endpoints.
Status | Completed |
Enrollment | 61 |
Est. completion date | May 1, 2018 |
Est. primary completion date | April 1, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 70 Years |
Eligibility |
Inclusion Criteria:- Males and females 20 - 70 years - 20 kg/m2 > BMI < 35 kg/m2 - systolic BP < 175 mmHg, diastolic BP < 105 mmHg - Serum 25(OH)D level < 50 nmol/L. Serum 25(OH)D < 50 nmol/L is considered as vitamin D deficiency, and accordingly, effects of vitamin D supplementation will be easier to detect than if the included subjects were vitamin D sufficient. - Hgb, SR, CRP, creatinine < 130 umol/L in males, < 120 umol/L in females, calcium, FT4 and TSH within the normal reference range; ASAT < 90 mU/L ALAT < 140 U/L, HbA1c < 6.6 % - The subjects must agree not to take any vitamin D supplementation, including cod liver oil or "mølje", use solarium or go on sunny vacation during the intervention period. Exclusion Criteria: - subjects allergic to peanuts - subjects with primary hyperparathyroidism - granulomatous diseases (sarcoidosis, tuberculosis, Wegner's granulomatosis) - diabetes - renal stones the last five years - subjects seriously ill (or with chronic disease) and unfit for participation in the study (as judged by one of the study doctors) - subjects using vitamin D supplements exceeding 800 IU per day or active vitamin D drugs (Rocaltrol or Etalpha) - pregnancy |
Country | Name | City | State |
---|---|---|---|
Norway | University Hospital of North Norway | Tromsø |
Lead Sponsor | Collaborator |
---|---|
University of Tromso |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Hepcidin change | Difference between vitamin D given as a bolus 160 000IU vs 4000 IU regarding change in serum hepcidin | 4 weeks | |
Secondary | Difference in serum PTH after 1 month | Difference between vitamin D given as a bolus 160 000IU vs 4000 IU regarding change in serum PTH, cathelicidin, RNA expression and micro RNA in peripheral blood, telomerase activity and the ratio between 1,25(OH)2D and 24,25(OH)2D, after 1 month | 4 weeks | |
Secondary | Difference in micro RNA Expression after 1 month | Difference between vitamin D given as a bolus 160 000IU vs 4000 IU | 4 weeks | |
Secondary | Difference in serum cathelicidin after 1 month | Difference between vitamin D given as a bolus 160 000IU vs 4000 IU | 4 weeks | |
Secondary | Difference in RNA Expression after 1 month | Difference between vitamin D given as a bolus 160 000IU vs 4000 IU | 4 weeks | |
Secondary | Difference in telomerase Activity after 1 month | Difference between vitamin D given as a bolus 160 000IU vs 4000 IU | 4 weeks | |
Secondary | Difference in ratio between 1,24(OH)2D and 24,24(OH)2D after 1 month | Difference between vitamin D given as a bolus 160 000IU vs 4000 IU | 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
Not yet recruiting |
NCT05214040 -
Vitamin D Insufficiency inVestigation Among hospitaLizeD Inpatients
|
||
Completed |
NCT02802449 -
To Study the Nutri-Genomic Response of Vit-D Supplementation in African-Americans
|
N/A | |
Recruiting |
NCT00992797 -
Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian Ethnicity
|
Phase 2 | |
Completed |
NCT00960232 -
Vitamin D, Blood Pressure, Lipids, Infection and Depression
|
Phase 3 | |
Completed |
NCT02543671 -
Investigation of Vitamin D3 Enriched, Reduced-fat Yellow Cheese Efficacy to Prevent Vitamin D Deficiency
|
N/A | |
Completed |
NCT01793402 -
Vitamin D Status and the Adequacy of Vitamin D Intake in Early Preterm Infants
|
N/A | |
Completed |
NCT01240213 -
Vitamin D, Diet and Activity Study
|
N/A | |
Completed |
NCT00887666 -
Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure
|
N/A | |
Completed |
NCT05425914 -
Impact of Vitamin D3 Supplementation in Non-Sjogren Dry Eye Patients With Low Serum Vitamin D Level
|
Phase 3 | |
Not yet recruiting |
NCT04829487 -
The Role of Vitamin D Supplementation on Pain in Women With Primary Dysmenorrhea and Hypovitaminosis D
|
N/A | |
Completed |
NCT05372224 -
Effect of Vitamin D and Denosumab on Bone Remodelling in Women With Postmenopausal Osteoporosis
|
N/A | |
Completed |
NCT02101151 -
Effect of Vitamin D Supplementation on the Metabolic Control and Body Composition of Type 2 Diabetes Subjects in Ajman (UAE)
|
N/A | |
Completed |
NCT00695474 -
Vitamin D and Type 2 Diabetes - a Cross Sectional Study
|
N/A | |
Completed |
NCT02534714 -
Analysis of Hypovitaminosis D and Osteopenia/Osteoporosis in Spinal Disease Patients Who Underwent a Spinal Fusion at Illinois Neurological Institute, Peoria, IL., a Retrospective Review From November 1, 2012 to October 31, 2014 and Prospective Pilot From July 1, 2015-June 30, 2016
|
||
Completed |
NCT02434380 -
Effect of Vitamin D Replacement on Maternal and Neonatal Outcomes
|
Phase 3 | |
Withdrawn |
NCT00944606 -
Vitamin D Versus Placebo in the Treatment of Vague Musculoskeletal Pain in Children
|
N/A | |
Recruiting |
NCT06138249 -
Cholecalciferol and Calcifediol Are Both Useful to Improve Vitamin D Serum Levels
|
N/A | |
Completed |
NCT05346419 -
Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients
|
N/A | |
Completed |
NCT03381378 -
Vitamin D and Hand Grip Strength at 5 Years in Odense Child Cohort
|
N/A |